BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 1,300 shares, a growth of 18.2% from the October 15th total of 1,100 shares. Based on an average daily volume of 1,700 shares, the days-to-cover ratio is presently 0.8 days.

BioSyent Stock Down 1.3 %

Shares of OTCMKTS BIOYF traded down $0.10 during mid-day trading on Friday, hitting $7.83. 4,212 shares of the company’s stock traded hands, compared to its average volume of 2,109. BioSyent has a 1 year low of $5.83 and a 1 year high of $8.90. The company’s 50-day moving average is $8.00 and its two-hundred day moving average is $7.42.

BioSyent Increases Dividend

The business also recently announced a dividend, which was paid on Sunday, September 15th. Stockholders of record on Thursday, September 5th were issued a $0.0334 dividend. This is a boost from BioSyent’s previous dividend of $0.03. The ex-dividend date was Wednesday, September 4th. This represents a dividend yield of 1.72%.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.